These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37551423)

  • 1. Phenotypic defects from the expression of wild-type and pathogenic TATA-binding proteins in new Drosophila models of Spinocerebellar Ataxia Type 17.
    Patel N; Alam N; Libohova K; Dulay R; Todi SV; Sujkowski A
    G3 (Bethesda); 2023 Sep; 13(10):. PubMed ID: 37551423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinocerebellar Ataxia Type 17 (SCA17).
    Toyoshima Y; Takahashi H
    Adv Exp Med Biol; 2018; 1049():219-231. PubMed ID: 29427105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deactivation of TBP contributes to SCA17 pathogenesis.
    Hsu TC; Wang CK; Yang CY; Lee LC; Hsieh-Li HM; Ro LS; Chen CM; Lee-Chen GJ; Su MT
    Hum Mol Genet; 2014 Dec; 23(25):6878-93. PubMed ID: 25104854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
    Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
    Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.
    Yang Y; Yang S; Guo J; Cui Y; Tang B; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(38):9101-9115. PubMed ID: 28821675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms and Therapeutics for SCA17.
    Liu Q; Pan Y; Li XJ; Li S
    Neurotherapeutics; 2019 Oct; 16(4):1097-1105. PubMed ID: 31317427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.
    Zühlke C; Dalski A; Schwinger E; Finckh U
    BMC Med Genet; 2005 Jul; 6():27. PubMed ID: 15989694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digenic inheritance of STUB1 variants and TBP polyglutamine expansions explains the incomplete penetrance of SCA17 and SCA48.
    Magri S; Nanetti L; Gellera C; Sarto E; Rizzo E; Mongelli A; Ricci B; Fancellu R; Sambati L; Cortelli P; Brusco A; Bruzzone MG; Mariotti C; Di Bella D; Taroni F
    Genet Med; 2022 Jan; 24(1):29-40. PubMed ID: 34906452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.
    Shah AG; Friedman MJ; Huang S; Roberts M; Li XJ; Li S
    Hum Mol Genet; 2009 Nov; 18(21):4141-52. PubMed ID: 19643914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically modified rodent models of SCA17.
    Cui Y; Yang S; Li XJ; Li S
    J Neurosci Res; 2017 Aug; 95(8):1540-1547. PubMed ID: 27859490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-expanded allele spinocerebellar ataxia 17: imaging and phenotypic variability.
    Paolini Paoletti F; Prontera P; Nigro P; Simoni S; Cappelletti G; Filidei M; Calabresi P; Parnetti L; Tambasco N
    Neurol Sci; 2021 Oct; 42(10):4309-4315. PubMed ID: 34031796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinocerebellar ataxia type 17-digenic TBP/STUB1 disease: neuropathologic features of an autopsied patient.
    Saito R; Tada Y; Oikawa D; Sato Y; Seto M; Satoh A; Kume K; Ueki N; Nakashima M; Hayashi S; Toyoshima Y; Tokunaga F; Kawakami H; Kakita A
    Acta Neuropathol Commun; 2022 Dec; 10(1):177. PubMed ID: 36476347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17).
    Rolfs A; Koeppen AH; Bauer I; Bauer P; Buhlmann S; Topka H; Schöls L; Riess O
    Ann Neurol; 2003 Sep; 54(3):367-75. PubMed ID: 12953269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex Ataxia-Dementia Phenotype in Patients with Digenic TBP/STUB1 Spinocerebellar Ataxia.
    Nanetti L; Magri S; Fichera M; Castaldo A; Nigri A; Pinardi C; Mongelli A; Sarro L; Pareyson D; Grisoli M; Gellera C; Di Bella D; Mariotti C; Taroni F
    Mov Disord; 2023 Apr; 38(4):665-675. PubMed ID: 36799493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients.
    Mariotti C; Alpini D; Fancellu R; Soliveri P; Grisoli M; Ravaglia S; Lovati C; Fetoni V; Giaccone G; Castucci A; Taroni F; Gellera C; Di Donato S
    J Neurol; 2007 Nov; 254(11):1538-46. PubMed ID: 17934876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers.
    Kelp A; Koeppen AH; Petrasch-Parwez E; Calaminus C; Bauer C; Portal E; Yu-Taeger L; Pichler B; Bauer P; Riess O; Nguyen HP
    J Neurosci; 2013 May; 33(21):9068-81. PubMed ID: 23699518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advance in research on spinocerebellar ataxia 17].
    Zhang J; Gu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):44-7. PubMed ID: 24510561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinocerebellar ataxia 17: full phenotype in a 41 CAG/CAA repeats carrier.
    Origone P; Gotta F; Lamp M; Trevisan L; Geroldi A; Massucco D; Grazzini M; Massa F; Ticconi F; Bauckneht M; Marchese R; Abbruzzese G; Bellone E; Mandich P
    Cerebellum Ataxias; 2018; 5():7. PubMed ID: 29564144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome.
    Ren J; Jegga AG; Zhang M; Deng J; Liu J; Gordon CB; Aronow BJ; Lu LJ; Zhang B; Ma J
    Hum Mol Genet; 2011 Sep; 20(17):3424-36. PubMed ID: 21653638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.
    Huang S; Yang S; Guo J; Yan S; Gaertig MA; Li S; Li XJ
    Cell Rep; 2015 Oct; 13(1):196-208. PubMed ID: 26387956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.